AJR
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Choi, J.-Y.
Right arrow Articles by Choi, B. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Choi, J.-Y.
Right arrow Articles by Choi, B. I.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?

Hilar Cholangiocarcinoma: Role of Preoperative Imaging with Sonography, MDCT, MRI, and Direct Cholangiography

Jin-Young Choi1, Myeong-Jin Kim1, Jeong Min Lee2, Ki Whang Kim1, Jae Young Lee2, Joon Koo Han2 and Byung Ihn Choi2

1 Department of Radiology, Research Institute of Radiological Science, Institute of Gastroenterology, Yonsei University Health System, Seodaemun-ku Shinchon-dong 134, Seoul, 120-752, Republic of Korea.
2 Department of Radiology, Seoul National University Hospital, Seoul, Republic of Korea.


Figure 1
View larger version (145K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1A 63-year-old man with hilar cholangiocarcinoma. Intercostal sonographic scan through common hepatic duct shows well-defined soft-tissue intraductal mass (white arrow) within dilated intrahepatic duct (black arrow). S8 = segment VIII.

 

Figure 2
View larger version (197K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1B 63-year-old man with hilar cholangiocarcinoma. Contrast-enhanced CT scan barely depicts intraductal papillary tumor (arrow). Papillary tumor is more easily seen with sonography than with CT.

 

Figure 3
View larger version (57K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1C 63-year-old man with hilar cholangiocarcinoma. Drawing depicts intraductal papillary-type cholangiocarcinoma at hepatic hilum.

 

Figure 4
View larger version (138K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1D 63-year-old man with hilar cholangiocarcinoma. Photograph of surgical specimen shows papillary tumor (arrow).

 

Figure 5
View larger version (152K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 2A 58-year-old man with hilar cholangiocarcinoma. Subcostal oblique gray-scale sonographic scan through porta hepatis shows abrupt narrowing of right intrahepatic duct (black arrows) secondary to infiltrating tumor (white arrow).

 

Figure 6
View larger version (67K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 2B 58-year-old man with hilar cholangiocarcinoma. Drawing shows periductal infiltrating-type cholangiocarcinoma.

 

Figure 7
View larger version (166K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 2C 58-year-old man with hilar cholangiocarcinoma. Contrast-enhanced CT scan shows tumor (white arrows) infiltrating right portal vein (black arrow).

 

Figure 8
View larger version (153K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 3A 55-year-old man with hilar cholangiocarcinoma. Contrast-enhanced sonographic scan shows extent of tumor at hilum (black arrows). Right hepatic artery (white arrows) and dilated duct (arrowhead) are enhanced.

 

Figure 9
View larger version (171K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 3B 55-year-old man with hilar cholangiocarcinoma. CT scan shows hilar mass (black arrow) and dilated right hepatic duct (white arrow).

 

Figure 10
View larger version (113K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 4A 60-year-old woman with hilar cholangiocarcinoma. Radial intraductal sonographic image shows circumferential wall thickening (arrows).

 

Figure 11
View larger version (201K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 4B 60-year-old woman with hilar cholangiocarcinoma. Coronal T2-weighted MR image shows bile duct wall thickening (arrows).

 

Figure 12
View larger version (159K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 4C 60-year-old woman with hilar cholangiocarcinoma. Cholangiogram shows stenosis in proximal and mid portions of extrahepatic duct (arrow).

 

Figure 13
View larger version (166K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 5A 67-year-old man with hilar cholangiocarcinoma, Bismuth-Corlette type 3a. Oblique axial reformatted (A), oblique coronal reformatted (B and C), and curved planar (D) MDCT scans along bile duct show tumor involves primary confluence (white arrow, A–C) and right secondary confluence (arrow, D). Right hepatic artery (black arrows, C) is invaded by tumor.

 

Figure 14
View larger version (153K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 5B 67-year-old man with hilar cholangiocarcinoma, Bismuth-Corlette type 3a. Oblique axial reformatted (A), oblique coronal reformatted (B and C), and curved planar (D) MDCT scans along bile duct show tumor involves primary confluence (white arrow, A–C) and right secondary confluence (arrow, D). Right hepatic artery (black arrows, C) is invaded by tumor.

 

Figure 15
View larger version (166K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 5C 67-year-old man with hilar cholangiocarcinoma, Bismuth-Corlette type 3a. Oblique axial reformatted (A), oblique coronal reformatted (B and C), and curved planar (D) MDCT scans along bile duct show tumor involves primary confluence (white arrow, A–C) and right secondary confluence (arrow, D). Right hepatic artery (black arrows, C) is invaded by tumor.

 

Figure 16
View larger version (173K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 5D 67-year-old man with hilar cholangiocarcinoma, Bismuth-Corlette type 3a. Oblique axial reformatted (A), oblique coronal reformatted (B and C), and curved planar (D) MDCT scans along bile duct show tumor involves primary confluence (white arrow, A–C) and right secondary confluence (arrow, D). Right hepatic artery (black arrows, C) is invaded by tumor.

 

Figure 17
View larger version (192K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 6A 67-year-old man with Klatskin's tumor, type 3a. Early arterial (A), late arterial (B), and portal venous (C and D) phase CT scans. Late arterial phase is used to maximize enhancement of tumor in hilar region (arrow, B). Portal venous phase is suitable for evaluating portal vein, adjacent liver invasion, and lymph node metastasis (arrows, D).

 

Figure 18
View larger version (196K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 6B 67-year-old man with Klatskin's tumor, type 3a. Early arterial (A), late arterial (B), and portal venous (C and D) phase CT scans. Late arterial phase is used to maximize enhancement of tumor in hilar region (arrow, B). Portal venous phase is suitable for evaluating portal vein, adjacent liver invasion, and lymph node metastasis (arrows, D).

 

Figure 19
View larger version (185K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 6C 67-year-old man with Klatskin's tumor, type 3a. Early arterial (A), late arterial (B), and portal venous (C and D) phase CT scans. Late arterial phase is used to maximize enhancement of tumor in hilar region (arrow, B). Portal venous phase is suitable for evaluating portal vein, adjacent liver invasion, and lymph node metastasis (arrows, D).

 

Figure 20
View larger version (189K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 6D 67-year-old man with Klatskin's tumor, type 3a. Early arterial (A), late arterial (B), and portal venous (C and D) phase CT scans. Late arterial phase is used to maximize enhancement of tumor in hilar region (arrow, B). Portal venous phase is suitable for evaluating portal vein, adjacent liver invasion, and lymph node metastasis (arrows, D).

 

Figure 21
View larger version (55K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 7A Modified T categorization in American Joint Committee on Cancer system proposed by Memorial Sloan–Kettering group [21]. Drawings show T1 tumors are confined to right, left, or confluence of bile ducts without portal venous involvement in liver atrophy.

 

Figure 22
View larger version (53K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 7B Modified T categorization in American Joint Committee on Cancer system proposed by Memorial Sloan–Kettering group [21]. Drawings show T1 tumors are confined to right, left, or confluence of bile ducts without portal venous involvement in liver atrophy.

 

Figure 23
View larger version (50K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 7C Modified T categorization in American Joint Committee on Cancer system proposed by Memorial Sloan–Kettering group [21]. Drawings show T2 tumors have same attributes as T1 tumors but are accompanied by ipsilateral liver atrophy.

 

Figure 24
View larger version (64K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 7D Modified T categorization in American Joint Committee on Cancer system proposed by Memorial Sloan–Kettering group [21]. Drawings show T2 tumors have same attributes as T1 tumors but are accompanied by ipsilateral liver atrophy.

 

Figure 25
View larger version (59K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 7E Modified T categorization in American Joint Committee on Cancer system proposed by Memorial Sloan–Kettering group [21]. Drawings show T3 tumors have same classifiers as T1 tumors but have ipsilateral portal venous atrophy without main portal vein involvement. Patients with T3 tumors are considered poor candidates for surgery. However, some Bismuth type 4 tumors with favorable anatomic features or short-segment invasion of main portal vein may not be absolute contraindication to curative resection.

 

Figure 26
View larger version (55K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 7F Modified T categorization in American Joint Committee on Cancer system proposed by Memorial Sloan–Kettering group [21]. Drawings show T3 tumors have same classifiers as T1 tumors but have ipsilateral portal venous atrophy without main portal vein involvement. Patients with T3 tumors are considered poor candidates for surgery. However, some Bismuth type 4 tumors with favorable anatomic features or short-segment invasion of main portal vein may not be absolute contraindication to curative resection.

 

Figure 27
View larger version (61K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 7G Modified T categorization in American Joint Committee on Cancer system proposed by Memorial Sloan–Kettering group [21]. Drawings show T3 tumors have same classifiers as T1 tumors but have ipsilateral portal venous atrophy without main portal vein involvement. Patients with T3 tumors are considered poor candidates for surgery. However, some Bismuth type 4 tumors with favorable anatomic features or short-segment invasion of main portal vein may not be absolute contraindication to curative resection.

 

Figure 28
View larger version (57K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 7H Modified T categorization in American Joint Committee on Cancer system proposed by Memorial Sloan–Kettering group [21]. Drawings show T3 tumors have same classifiers as T1 tumors but have ipsilateral portal venous atrophy without main portal vein involvement. Patients with T3 tumors are considered poor candidates for surgery. However, some Bismuth type 4 tumors with favorable anatomic features or short-segment invasion of main portal vein may not be absolute contraindication to curative resection.

 

Figure 29
View larger version (54K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 7I Modified T categorization in American Joint Committee on Cancer system proposed by Memorial Sloan–Kettering group [21]. Drawings show T3 tumors have same classifiers as T1 tumors but have ipsilateral portal venous atrophy without main portal vein involvement. Patients with T3 tumors are considered poor candidates for surgery. However, some Bismuth type 4 tumors with favorable anatomic features or short-segment invasion of main portal vein may not be absolute contraindication to curative resection.

 

Figure 30
View larger version (162K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 8A 62-year-old woman with hilar cholangiocarcinoma. Oblique coronal MDCT scan shows relation between hilar tumor (thick black arrow) and left hepatic artery (white arrow). Hepatic metastasis is present in segment IV (thin black arrow).

 

Figure 31
View larger version (153K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 8B 62-year-old woman with hilar cholangiocarcinoma. Oblique axial MDCT scan shows tumor involvement along biliary tree (arrows).

 

Figure 32
View larger version (120K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 9A 64-year-old woman with Klatskin's tumor. Oblique coronal MDCT scans show endoscopic retrograde biliary drainage tube (arrow) in bile duct makes it difficult to evaluate biliary extension of tumor.

 

Figure 33
View larger version (119K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 9B 64-year-old woman with Klatskin's tumor. Oblique coronal MDCT scans show endoscopic retrograde biliary drainage tube (arrow) in bile duct makes it difficult to evaluate biliary extension of tumor.

 

Figure 34
View larger version (121K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 10A 55-year-old man with hilar cholangiocarcinoma, Bismuth-Corlette type 4. Two-dimensional MR cholangiopancreatographic image shows hilar bile duct tumor.

 

Figure 35
View larger version (198K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 10B 55-year-old man with hilar cholangiocarcinoma, Bismuth-Corlette type 4. T2-weighted images show tumor encasement of right hepatic artery (arrow, B) and hepatic parenchymal invasion (arrowhead, C).

 

Figure 36
View larger version (183K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 10C 55-year-old man with hilar cholangiocarcinoma, Bismuth-Corlette type 4. T2-weighted images show tumor encasement of right hepatic artery (arrow, B) and hepatic parenchymal invasion (arrowhead, C).

 

Figure 37
View larger version (100K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 11A 54-year-old man with Klatskin's tumor, type 4. Two-dimensional thick-slab RARE (A) and maximum-intensity-projection (B) MR cholangiopancreatographic images obtained with 3D navigator-triggered turbo spin-echo technique show malignant hilar obstruction.

 

Figure 38
View larger version (116K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 11B 54-year-old man with Klatskin's tumor, type 4. Two-dimensional thick-slab RARE (A) and maximum-intensity-projection (B) MR cholangiopancreatographic images obtained with 3D navigator-triggered turbo spin-echo technique show malignant hilar obstruction.

 

Figure 39
View larger version (162K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 12A 67-year-old man with Klatskin's tumor. Three-dimensional dynamic T1-weighted gradient-echo MR image in arterial phase shows relation between right hepatic artery (white arrows) and tumor (black arrow).

 

Figure 40
View larger version (175K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 12B 67-year-old man with Klatskin's tumor. Three-dimensional dynamic T1-weighted gradient-echo MR images in portal venous phase show infiltrating tumor (arrow, C and D) and lymph node metastasis at porta hepatis (arrows, E).

 

Figure 41
View larger version (176K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 12C 67-year-old man with Klatskin's tumor. Three-dimensional dynamic T1-weighted gradient-echo MR images in portal venous phase show infiltrating tumor (arrow, C and D) and lymph node metastasis at porta hepatis (arrows, E).

 

Figure 42
View larger version (175K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 12D 67-year-old man with Klatskin's tumor. Three-dimensional dynamic T1-weighted gradient-echo MR images in portal venous phase show infiltrating tumor (arrow, C and D) and lymph node metastasis at porta hepatis (arrows, E).

 

Figure 43
View larger version (182K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 12E 67-year-old man with Klatskin's tumor. Three-dimensional dynamic T1-weighted gradient-echo MR images in portal venous phase show infiltrating tumor (arrow, C and D) and lymph node metastasis at porta hepatis (arrows, E).

 

Figure 44
View larger version (132K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 12F 67-year-old man with Klatskin's tumor. MR cholangiopancreatographic image shows tumor involvement of primary confluence of bile duct (arrow).

 

Figure 45
View larger version (121K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 13A 61-year-old man with Bismuth-Corlette type 4 cholangiocarcinoma. Percutaneous cholangiogram shows bilateral tumor involvement of secondary confluence level (arrows).

 

Figure 46
View larger version (117K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 13B 61-year-old man with Bismuth-Corlette type 4 cholangiocarcinoma. Percutaneous cholangiogram shows metallic biliary stents inserted into bilateral hepatic ducts as palliative treatment.

 

Figure 47
View larger version (152K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 14A 63-year-old man with Bismuth-Corlette type 4 cholangiocarcinoma. Percutaneous cholangiogram through left hepatic duct does not depict right hepatic duct proximal to occlusion.

 

Figure 48
View larger version (174K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 14B 63-year-old man with Bismuth-Corlette type 4 cholangiocarcinoma. Maximum intensity projection of MR cholangiopancreatographic image clearly shows bilateral dilated hepatic ducts proximal to hilar mass (arrows).

 

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American Roentgen Ray Society.